The Scientific Research Team at KalVista Pharmaceuticals is dedicated to the discovery and development of small molecule protease inhibitors. This collaborative group of research chemists, medicinal chemists, and scientists focuses on designing and synthesizing new compounds, conducting in vitro and in vivo studies, and advancing promising candidates through preclinical and clinical evaluation to address a range of diseases.
Alicja Obara
Scientist Medicinal Chemistry
Andrew Morrell
Research Chemist
Christophe Fromont
Principal Scientist, Medicinal...
Emily Mitchell
Staff Accountant
Heather Edwardson
Senior Scientist II
Kirstie Speer
Scientist I, Invitro DMPK
Mitchell Childs
Senior Scientist
Natasha Bayliss
Principal Scientist
Sally Hampton
VP Research
William Greves
Senior Scientist, Medicinal Ch...
View all